A comparative scientific review of tirzepatide and semaglutide, examining receptor pharmacology, dual GIP/GLP-1 agonism versus selective GLP-1 activation,
Read more Tirzepatide vs. Semaglutide: Comparative Pharmacology and Research Evidence
While approved for diabetes and weight management, tirzepatide is under active investigation for broader cardiometabolic indications. Emerging clinical tri
Read more Tirzepatide in Emerging Indications: Liver, Kidney, and Cardiovascular Research
A comprehensive review of the clinical evidence for tirzepatide, examining glycemic and weight loss outcomes across the landmark SURPASS and SURMOUNT phase
Read more Tirzepatide Clinical Evidence: What the SURPASS and SURMOUNT Trials Show
A structured Minto Pyramid review examining tirzepatide’s pharmacology, evidence hierarchy, and dual GIP/GLP-1 receptor agonism in metabolic and endocrine